Wyeth’s Bazedoxifene Reduces Vertebral Fractures in Postmenopausal Women

by Gopalan on  September 20, 2009 at 11:05 AM Drug News
  •   Print
  •   Share
  •   Comments
  •  Text 
Wyeth Pharmaceuticals, a US major, has reported promising results for bazedoxifene from a placebo-controlled Phase 3 study. The drug, a selective estrogen receptor modulator (SERM), is under clinical investigation for the prevention and treatment of postmenopausal osteoporosis.

The trial of bazedoxifene 20 mg indicated a significant reduction in new vertebral fractures in postmenopausal women with osteoporosis, the company said in a press release.

The results were from a two-year extension of a three-year Phase 3 trial, which enrolled 7,492 generally healthy postmenopausal women aged 55 to 85 years with osteoporosis.

At five years, the study showed that the incidence of new vertebral fractures was significantly reduced in the bazedoxifene 20 mg group (4.5%) and in the group transitioned from bazedoxifene 40 mg to 20 mg (3.9%) compared with placebo (6.8%).

These and other data were presented at the American Society for Bone and Mineral Research (ASBMR) Annual Meeting in Denver, Colorado.

“These new data are important in that they suggest the reduction in vertebral fracture risk with bazedoxifene seen at five years is comparable to that seen at three years,” says Stuart Silverman,  Clinical Professor of Medicine at the University of California, Los Angeles and Cedars-Sinai Medical Center, and the study’s lead investigator.

But Wyeth has had trouble getting the drug approved in the U.S. In May, it received, for the third time, a letter from the FDA delaying an approval decision. The FDA wanted further analysis about the rate of stroke and other events related to blood clots, and also had some questions about data collection.

Page 1 Page 1 | 2  Next
 Email Email   RSS Feeds RSS Feeds   Print this page Print   Save this page Save   Link Link   Syndicate Syndicate   Comments Comments   Bookmark and Share
 
Comment & Contribute
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters

Notify me when reply is posted
I agree to the terms and conditions
  
If you have a question about health related issues, you can now post it in our Ask An Expert section on our community website Medwonders.com and get answers from our panel of experts.
X

Medwonders Health Network

  • Health News Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Archive
Date :
Category :
Keyword :
  • News Quick Links
News Central Health Watch
Latest Health News Health In Focus
News Category (500+) Breaking Health News
Popular News Celebrating Life
Health News and Press Release Medindia - Exclusive
News Photo Gallery India Special
News Video Gallery Lifestyle and Wellness
News From Other Resources
News Categories:  
Kidney Health Center

Drug Related News

» Schizophrenia Drug Differentiates Cancer Stem Cells into Less Threatening Cells » Docs Who Seldom Meet Drug Reps Continue to Prescribe Drugs With FDA “Black Box” Warnings
» Revision in Quality Standards for Heparin » Acne Drug Users At High Risk of Developing Eye Infections
» Patients Who Take Antidepressants When in ICU More Likely to Die » New Tablet Coating Product by Ideal Cures, In Geneva
» Prednisolone Benefits Patients With Bell's Palsy » 'Orphan' Sleep Drug may Fight Cancer
Read More >>